2v00: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
|PDB= 2v00 |SIZE=350|CAPTION= <scene name='initialview01'>2v00</scene>, resolution 1.55Å | |PDB= 2v00 |SIZE=350|CAPTION= <scene name='initialview01'>2v00</scene>, resolution 1.55Å | ||
|SITE= <scene name='pdbsite=AC1:Gol+Binding+Site+For+Chain+A'>AC1</scene>, <scene name='pdbsite=AC2:Gol+Binding+Site+For+Chain+A'>AC2</scene>, <scene name='pdbsite=AC3:Gol+Binding+Site+For+Chain+A'>AC3</scene>, <scene name='pdbsite=AC4:Act+Binding+Site+For+Chain+A'>AC4</scene>, <scene name='pdbsite=AC5:Act+Binding+Site+For+Chain+A'>AC5</scene> and <scene name='pdbsite=AC6:V15+Binding+Site+For+Chain+A'>AC6</scene> | |SITE= <scene name='pdbsite=AC1:Gol+Binding+Site+For+Chain+A'>AC1</scene>, <scene name='pdbsite=AC2:Gol+Binding+Site+For+Chain+A'>AC2</scene>, <scene name='pdbsite=AC3:Gol+Binding+Site+For+Chain+A'>AC3</scene>, <scene name='pdbsite=AC4:Act+Binding+Site+For+Chain+A'>AC4</scene>, <scene name='pdbsite=AC5:Act+Binding+Site+For+Chain+A'>AC5</scene> and <scene name='pdbsite=AC6:V15+Binding+Site+For+Chain+A'>AC6</scene> | ||
|LIGAND= <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand= | |LIGAND= <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=V15:2-AMINO-6-(2-PHENYLETHYL)PYRIMIDIN-4(3H)-ONE'>V15</scene> | ||
|ACTIVITY= [http://en.wikipedia.org/wiki/Endothiapepsin Endothiapepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.22 3.4.23.22] | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Endothiapepsin Endothiapepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.22 3.4.23.22] </span> | ||
|GENE= | |GENE= | ||
|DOMAIN= | |||
|RELATEDENTRY=[[1e5o|1E5O]], [[1e80|1E80]], [[1e81|1E81]], [[1e82|1E82]], [[1eed|1EED]], [[1ent|1ENT]], [[1gkt|1GKT]], [[1gvt|1GVT]], [[1gvu|1GVU]], [[1gvv|1GVV]], [[1gvw|1GVW]], [[1gvx|1GVX]], [[1od1|1OD1]], [[1oew|1OEW]], [[1oex|1OEX]] | |||
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2v00 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2v00 OCA], [http://www.ebi.ac.uk/pdbsum/2v00 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2v00 RCSB]</span> | |||
}} | }} | ||
| Line 30: | Line 33: | ||
[[Category: Geschwindner, S.]] | [[Category: Geschwindner, S.]] | ||
[[Category: Olsson, L L.]] | [[Category: Olsson, L L.]] | ||
[[Category: alzheimer's disease]] | [[Category: alzheimer's disease]] | ||
[[Category: aspartyl protease]] | [[Category: aspartyl protease]] | ||
| Line 46: | Line 46: | ||
[[Category: zymogen]] | [[Category: zymogen]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 05:06:48 2008'' | ||
Revision as of 05:06, 31 March 2008
| |||||||
| , resolution 1.55Å | |||||||
|---|---|---|---|---|---|---|---|
| Sites: | , , , , and | ||||||
| Ligands: | , , | ||||||
| Activity: | Endothiapepsin, with EC number 3.4.23.22 | ||||||
| Related: | 1E5O, 1E80, 1E81, 1E82, 1EED, 1ENT, 1GKT, 1GVT, 1GVU, 1GVV, 1GVW, 1GVX, 1OD1, 1OEW, 1OEX
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH COMPOUND 1
OverviewOverview
Fragment-based lead generation was applied to find novel small-molecule inhibitors of beta-secretase (BACE-1), a key target for the treatment of Alzheimer's disease. Fragment hits coming from a 1D NMR screen were characterized by BIAcore, and the most promising compounds were soaked into protein crystals to help the rational design of more potent hit analogues. Problems arising due to our inability to grow BACE-1 crystals at the biologically relevant pH at which the screen was run were overcome by using endothiapepsin as a surrogate aspartyl protease. Among others, we identified 6-substituted isocytosines as a novel warhead against BACE-1, and the accompanying paper in this journal describes how these were optimized to a lead series of nanomolar inhibitors.1.
About this StructureAbout this Structure
2V00 is a Single protein structure of sequence from Cryphonectria parasitica. Full crystallographic information is available from OCA.
ReferenceReference
Discovery of a novel warhead against beta-secretase through fragment-based lead generation., Geschwindner S, Olsson LL, Albert JS, Deinum J, Edwards PD, de Beer T, Folmer RH, J Med Chem. 2007 Nov 29;50(24):5903-11. Epub 2007 Nov 7. PMID:17985861
Page seeded by OCA on Mon Mar 31 05:06:48 2008
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCA- Pages with broken file links
- Cryphonectria parasitica
- Endothiapepsin
- Single protein
- Albert, J S.
- Beer, T De.
- Deinum, J.
- Edwards, P D.
- Folmer, R H.A.
- Geschwindner, S.
- Olsson, L L.
- Alzheimer's disease
- Aspartyl protease
- B- secretase
- Bace
- Fragment hit
- Fragment-based lead generation
- Hydrolase
- Isocytosine
- Protease
- Surrogate protein
- Zymogen